In the evening, we come back and do a self-examination and look at what we did well that day, what we couldve done better, and where we were most purpose-filled
The transition from an IV infusion or SC vial to an SC injection device requires several chemistry, manufacturing and controls (CMC) development activities, as well as clinical and non-clinical, depending on the timing and scope of the change: Formulation development Primary packaging selection and integration with formulation Device selection and device development Drug-device integration Drug product manufacturing process development Bridging studies Comparative stability studies, including real-time and accelerated stress stability and characterisation Non-clinical studies Clinical studies
An orthologue of the cor gene is involved in the exclusion of temperate lambdoid phages
doi: 10.1152/japplphysiol.91415.2008, 20
Still, some early clinical findings hint at potential uses in more specific contexts: Perioperative brain protection: A randomized controlled trial involving 155 liver surgery patients found that ALA reduced oxidative brain injury from anesthesia (sevoflurane) and improved cognitive recovery scores after surgery.31 Neurodegenerative conditions: In a small trial, ALA appeared to slow brain atrophy in patients with secondary progressive multiple sclerosis over a two-year period.32 While promising, this outcome still needs further confirmation
Researchers are responsible for maintaining proper laboratory handling procedures after receipt
